Israel isolates key coronavirus antibody in 'significant breakthrough' in quest for treatment for infection, claims defence minister

Israel has isolated a key coronavirus antibody at its main biological research laboratory, the Israeli defence minister said on Monday, calling the step a 'significant breakthrough' toward a possible treatment for the COVID-19 pandemic.

Reuters May 05, 2020 09:44:24 IST
Israel isolates key coronavirus antibody in 'significant breakthrough' in quest for treatment for infection, claims defence minister

Jerusalem: Israel has isolated a key coronavirus antibody at its main biological research laboratory, the Israeli defence minister said on Monday, calling the step a “significant breakthrough” toward a possible treatment for the COVID-19 pandemic.

The “monoclonal neutralising antibody” developed at the Israel Institute for Biological Research (IIBR) “can neutralise it (the disease-causing coronavirus) inside carriers’ bodies,” Defence Minister Naftali Bennett said in a statement.

The statement added that Bennett visited the IIBR on Monday where he was briefed “on a significant breakthrough in finding an antidote for the coronavirus”.

It quoted IIBR Director Shmuel Shapira as saying that the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it.

Israel isolates key coronavirus antibody in significant breakthrough in quest for treatment for infection claims defence minister

Representational image. Image by HenkieTenk from Pixabay.

The IIBR has been leading Israeli efforts to develop a treatment and vaccine for the coronavirus, including the testing of blood from those who recovered from COVID-19, the respiratory disease caused by the virus.

Antibodies in such samples - immune-system proteins that are residues of successfully overcoming the coronavirus - are widely seen as a key to developing a possible cure.

The antibody reported as having been isolated at the IIBR is monoclonal, meaning it was derived from a single recovered cell and is thus potentially of more potent value in yielding a treatment.

Elsewhere, there have been coronavirus treatments developed from antibodies that are polyclonal or derived from two or more cells of different ancestry, the magazine Science Direct reported in its May issue.

Israel was one of the first countries to close its borders and impose increasingly stringent restrictions on movement to hamper the domestic coronavirus outbreak. It has reported 16,246 cases and 235 deaths from the illness.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

WHO says delay in AstraZeneca COVID-19 vaccine trial is a 'wake-up call'; but won't delay the vaccine
science

WHO says delay in AstraZeneca COVID-19 vaccine trial is a 'wake-up call'; but won't delay the vaccine

An independent committee has been created to review the study’s safety data will let them know when it is safe to continue with the trials.

Over 1 lakh patients cured in past 24 hrs, India's COVID-19 recovery rate rises to 80.86%; total cases at 55.62 lakh
India

Over 1 lakh patients cured in past 24 hrs, India's COVID-19 recovery rate rises to 80.86%; total cases at 55.62 lakh

With 75,809 new COVID-19 cases being reported, the overall figure reached 55,62,663. The case fatality rate stands at 1.6 percent

India records 96,551 COVID-19 infections for first time in single day, taking total over 45.62 lakh
India

India records 96,551 COVID-19 infections for first time in single day, taking total over 45.62 lakh

After 1,209 fatalities were reported in the past 24 hours, India's COVID-19 toll climbed to 76,271 while, the recoveries crossed 35 lakh on Friday